Log In
BCIQ
Print this Print this
 

CX 009

  Manage Alerts
Collapse Summary General Information
Company CeNeRx BioPharma Inc.
DescriptionReversible inhibitor of monoamine oxidase-A (MOA)
Molecular Target Monoamine oxidase (MAO)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today